Glenmark’s Baddi manufacturing unit receives GMP certificate from European regulator

By: |
New Delhi | Published: December 16, 2019 11:54:07 AM

"The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice (GMP) laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO," Glenmark Pharmaceuticals said in a regulatory filing.

Glenmark Pharmaceuticals, Baddi manufacturing, GMP certificate, Glenmark gmp certificateThe shares of Glenmark Pharmaceuticals were trading at Rs 347.00, up 1.96 per cent on BSE in the morning trade.

Glenmark Pharmaceuticals on Monday said that its Baddi manufacturing unit has received Good Manufacturing Practice (GMP) certificate from European regulator State Institute for Drug control (SUKL). “The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice (GMP) laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO,” Glenmark Pharmaceuticals said in a regulatory filing.

Baddi manufacturing unit of Glenmark Pharmaceuticals was inspected by SUKL in the week of October 21 this year, the filing added. The shares of Glenmark Pharmaceuticals were trading at Rs 347.00, up 1.96 per cent on BSE in the morning trade.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1BSNL wants govt to pay its Rs 5,000-crore AGR dues
2National Insurance seeks Rs 6,000 crore before merger
3Air India’s MRO arm in talks with Vistara, SpiceJet for Boeing 737 contracts